|
Volumn 14, Issue 5, 2004, Pages 931-935
|
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
RAPAMYCIN;
ARTICLE;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
CHRONIC KIDNEY FAILURE;
COMPUTER ASSISTED TOMOGRAPHY;
DIABETIC NEPHROPATHY;
HUMAN;
KIDNEY TRANSPLANTATION;
KIDNEY TUMOR;
LEIOMYOSARCOMA;
LIVER TUMOR;
MALE;
MIDDLE AGED;
PATHOLOGY;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
DIABETIC NEPHROPATHIES;
HUMANS;
KIDNEY FAILURE, CHRONIC;
KIDNEY NEOPLASMS;
KIDNEY TRANSPLANTATION;
LEIOMYOSARCOMA;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
SIROLIMUS;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 20544472845
PISSN: 11073756
EISSN: None
Source Type: Journal
DOI: 10.3892/ijmm.14.5.931 Document Type: Article |
Times cited : (19)
|
References (0)
|